Daniel DiLorenzo, MD, PhD
Dan joined Santé in 2013 as an Entrepreneur In Residence and is focusing on identifying and creating game changing new ventures in the neurotechnology field. Dan is also completing a Functional Neurosurgery Fellowship at Rush University. Prior to Santé, while a neurosurgery resident, Dan founded BioNeuronics, renamed NeuroVista, which developed an implanted seizure advisory system and successfully demonstrated for the first time that seizures can be predicted in humans. Dan founded Barinetics, an early stage medical device venture based upon his autonomic modulation inventions.
Dan received several innovation awards, including the Lemelson-MIT $30,000 Student Innovation Award and the MIT Technology Review TR100 Award. He has 18 issued US patents for medical devices. Dan earned his SB and SM in electrical engineering and computer science from the Massachusetts Institute of Technology, MD from the joint Harvard Medical School/MIT Division of Health Sciences and Technology, PhD in mechanical rngineering at MIT, and MBA (MS in the management of technology) at the MIT Sloan School of Management. He has passed the patent bar exam and is registered to practice before the USPTO.